Embecta adds to earnings rally with another 9% advance (EMBC:NASDAQ)

Embecta Corp. (EMBC) shares climbed another 9% on Monday, extending a rally initiated by the medical device company's strong quarterly earnings release. This surge brings the total rally to over 26% since the previous session, driven by better-than-expected non-GAAP EPS and revenue, and raised fiscal guidance. While analysts remain neutral due to competitive pressures, some investors are bullish on the stock's momentum and potential for a short-squeeze.